RECRUITING

USCOM in Newly Diagnosed FGR Cases

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.

Official Title

Ultrasound Hemodynamic Assessment in Newly Diagnosed Fetal Growth Restriction: a Pilot Study

Quick Facts

Study Start:2024-07-02
Study Completion:2026-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06343051

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pregnant patients with a new diagnosis of fetal growth restriction (estimated fetal weight \<10th percentile or abdominal circumference \<10th percentile) in the third trimester (gestational age \>27w6d)
  1. * Multiple gestation
  2. * Fetal anomalies
  3. * Gestational diabetes or pregestational diabetes.

Contacts and Locations

Study Contact

Nicola F Tavella, MPH
CONTACT
212-241-3888
nicola.tavella@mssm.edu
Allison Perelman, MD
CONTACT
allison.perelman@mssm.edu

Principal Investigator

Nicola F Tavella, MPH
STUDY_DIRECTOR
Icahn School of Medicine at Mount Sinai
Rachel J Meislin, MD
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai

Study Locations (Sites)

Mount Sinai Hospital
New York, New York, 10029
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Nicola F Tavella, MPH, STUDY_DIRECTOR, Icahn School of Medicine at Mount Sinai
  • Rachel J Meislin, MD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-02
Study Completion Date2026-06

Study Record Updates

Study Start Date2024-07-02
Study Completion Date2026-06

Terms related to this study

Additional Relevant MeSH Terms

  • Fetal Growth Restriction
  • USCOM